Tracy Parrott

Therapeutic potential of ERK5 targeting in triple negative breast cancer

María Jesús Ortiz-Ruiz, Stela Álvarez-Fernández, Tracy Parrott et al. · Oncotarget · 2014 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Potent Antimyeloma Activity of a Novel ERK5/CDK Inhibitor

Stela Álvarez-Fernández, María Jesús Ortiz-Ruiz, Tracy Parrott et al. · Clinical Cancer Research · 2013 · 48 citations

Medicine, Oncology, Pharmacology +16

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text

Medicine, Cardiology, Internal Medicine +10

TG02, an Oral CDK9-Inhibitor, in Combination with Carfilzomib Demonstrated Objective Responses in Carfilzomib Refractory Multiple Myeloma Patients

Craig C. Hofmeister, Jesús G. Berdeja, David H. Vesole et al. · Blood · 2015 · 13 citations

Medicine, Oncology, Pharmacology +14